Vnitr Lek 2015, 61(Suppl 5):25-34

Arterial hypertension - multicirculus vitiosus vasorum

Peter Gavorník1,2,3,*, Andrej Dukát1,3, Ľudovít Gašpar1,3, Naďa Hučková1,3, Laura Slezáková1,3, Katarína Kusendová1,3, Gabriela Gubo1,2, Denisa Medová1,2, Xénia Faktorová1,2, Eva Gavorníková3,4
1 II. interná klinika LF UK a UN Bratislava, Slovenská republika, prednosta doc. MUDr. Ľudovít Gašpar, CSc.
2 Prvé angiologické pracovisko (PAP), vedúci lekár doc. MUDr. Peter Gavorník, PhD., mim. prof.
3 Sekcia angiológov Slovenskej lekárskej komory, predseda doc. MUDr. Peter Gavorník, PhD., mim. prof.
4 Ambulancia všeobecného lekára pre dospelých, poliklinika Ružinov, Bratislava Slovenská republika

Aim:
The aim of this review is to address documents and a number of studies on hypertension published in the last years in order to assess their contribution to our expanding knowledge of arterial hypertension.

Discussion:
Arterial hypertension is not defined by symptoms and signs but by numbers of blood pressure values. Arterial hypertension is vascular disease (vascular risk factor) of many vascular diseases (atherosclerosis; arteriolosclerosis/arteriolonecrosis/arteriolocalcinosis; arterial thrombosis; arterial embolism; arterial thromboembolism; arterial dissection; complicated arterial aneurysm) and other.

Conclusion:
Arterial hypertension is cause and consequence of functional (endothelial dysfunction) and of structural organovascular injury (multiorganomultivascular disease). Blood vessels are culprits, implements and victims of arterial hypertension and of organovascular arterial diseases.

Keywords: angiology, vascular medicine; arterial hypertension; blood vessels; internal medicine; organovascular arterial diseases; vascular diseases

Received: May 16, 2015; Accepted: September 30, 2015; Published: October 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gavorník P, Dukát A, Gašpar Ľ, Hučková N, Slezáková L, Kusendová K, et al.. Arterial hypertension - multicirculus vitiosus vasorum. Vnitr Lek. 2015;61(Supplementum 5):25-34.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281-1357. Go to original source... Go to PubMed...
    2. Filipová S, Dukát A, Škultétyová D. Aký je prínos nových odporúčaní pre diagnostiku a liečbu hypertenzie? Komentár k 2013 ESH/ESC Odporúčania pre manažment artériovej hypertenzie. Cardiology Lett 2014; 23(1): 5-9.
    3. James PA, Oparil S, Carter BL et al. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) Novelty and Significance. JAMA 2014; 311(5): 507-520. Erratum in JAMA 2014 7; 311(17): 1809. Go to original source... Go to PubMed...
    4. Li Q, Youn JY, Cai H. Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension. J Hypertens 2015; 33(6): 1128-1136. Go to original source... Go to PubMed...
    5. O'Brien E, Parati G, Stergiou G et al. European Society of Hypertension Position Paper on Ambulatory Blood Pressure Monitoring. J Hypertens 2013; 31(9): 1731-1768. Erratum in J Hypertens 2013; 31(12): 2467. Go to original source... Go to PubMed...
    6. Westerhof N, Westerhof BE. A review of methods to determine the functional arterial parameters stiffness and resistance. J Hypertens 2013; 31(9): 1769-1775. Go to original source... Go to PubMed...
    7. Uhlig K, Patel K, Ip S et al. Self-Measured Blood Pressure Monitoring in the Management of Hypertension: A Systematic Review and Meta-analysis. Ann Intern Med 2013; 159(3): 185-194. Go to original source... Go to PubMed...
    8. Gavorník P, Dukát A, Gašpar Ľ et al. Odporúčania Sekcie angiológov SLK pre manažment artériovej hypertenzie (2011). Cievy - páchateľky, nástroje i obete artériovej hypertenzie (cievnej choroby cievnych chorôb). Ateroskleróza 2011; 15(1-2): 79-84.
    9. Gavorník P. Artériová hypertenzia: Cievy - páchateľky, nástroje i obete artériovej hypertenzie. Odporúčania podľa Sekcie angiológov SLK pre manažment artériovej hypertenzie. I-med 2012; 2: 1-38. Dostupné z WWW: <http://www.i-med.sk/internisticke discipliny/angiológia>. ISSN 1338-4392.
    10. Gavorník P, Dukát A, Gašpar Ľ et al. Ambulantné monitorovanie krvného tlaku a končatinovocievna artériová choroba. Ateroskleróza 2014; 18(1-2): 389-400.
    11. Gavorník P, Dukát A, Gašpar Ľ. Akútne a chronické aortové choroby hrudníkovej a brušnej aorty u dospelých. Odporúčania Angiologickej sekcie Slovenskej lekárskej komory pre klasifikácia a diagnózu chorôb aorty (AS SLK, 2014). Vnitř Lék 2015; 61(1): 72-80.
    12. Gavorník P. Angiológia 2 pre všeobecných lekárov - Arteriológia. Bratislava: Dr. Josef Raabe: Bratislava 2014. ISBN 978-80-8140-168-8.
    13. Dukát A, Mistríková L, Baláž D et al. Izolovaná nočná hypertenzia - nová klinická jednotka, ktorá bola izolovaná z ambulantných monitorovaní krvného tlaku. Interní medicina pro praxi 2014; 16(4): 141-144.
    14. Gavorník P. Fixné antihypertenzné liekové dvojkombinácie vo farmakoterapii systémovej artériovej hypertenzie kategorizované v SR v roku 2015. Medikom/Medinews 2015; 5(3): 12-16.
    15. Erbel R, Aboyans V, Boileau C et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases. Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J 2014; 35(41): 2873-2926. Go to original source... Go to PubMed...
    16. Gašpar Ľ. 40. výročie vzniku prvého klinického angiologického pracoviska na Slovensku a 20. výročie založenia Angiologickej sekcie Slovenskej lekárskej komory. Medikom 2014; 4(1): 66-67.
    17. Rydén L, Grant PJ, Anker SD et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 2013; 34(39): 3035-3087. Erratum in: Eur Heart J 2014; 35(27): 1824. Go to original source... Go to PubMed...
    18. An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report. Expert Dyslipidemia Panel of the International Atherosclerosis Society. J Clin Lipidology 2014; 8(1): 29-60.
    19. Schwarcz AI, Quijano A, Olin JW et al. Internal medicine interns have a poor knowledge of peripheral arterial disease. Angiology 2012; 63(8): 597-602. Go to original source... Go to PubMed...
    20. Demer LL, Tintut Y Inflammatory, Metabolic, and Genetic Mechanisms of Vascular Calcification. Arterioscler Thromb Vasc Biol 2014; 34: 715-723. Go to original source... Go to PubMed...
    21. Brown NK, Zhou Z, Zhang J et al. Perivascular Adipose Tissue in Vascular Function and Disease. A Review of Current Research and Animal Models. Arterioscler Thromb Vasc Biol 2014; 34(8): 1621-1630. Go to original source... Go to PubMed...
    22. Kramer MHH, Bauer W, Dicker D et al. Working Group on Professional Issues, European Federation of Internal medicine (EFIM). The changing face of internal medicine: Patient centred care. Eur J Intern Med 2014; 25(2): 125-127. Go to original source... Go to PubMed...
    23. Inventory, classification and encyclopeadia of rare diseases, with genes involved. Dostupné na WWW: <http://www.orpha.net/consor/cgi-bin/index.php?lng=EN>.
    24. Arcidiacono MV, Traveset A, Rubinat E et al. Microangiopathy of large artery wall: neglected complication of diabetes mellitus. Atherosclerosis 2013; 228(1): 142-147. Go to original source... Go to PubMed...
    25. Saha SP, Ziada KM, Whayne TH Jr. TF Surgical, Interventional, and Device Innovations in the Management of Hypertension. Int J Angiol 2015; 24(1): 1-10. Go to original source... Go to PubMed...
    26. Sova M, Sovová E, Hobzová M et al. Studium souvislostí poruch spánku, obstrukční spánkové apnoe a vzniku a léčby arteriální hypertenze - módní vlna nebo dlouhodobý trend? Vnitř Lék 2015; 61(1): 50-55.
    27. Filipovský J, Widimský J jr. Ceral J et al. Diagnostické a léčebné postupy u arteriální hypertenze - verze 2012. Doporučení České společnosti pro hypertenzi. Vnitř Lék 2012; 58(10): 785-801. Go to PubMed...
    28. Widimský J jr. Léčba hypertenze u diabetes mellitus. Vnitř Lék 2015; 61(4): 335-337. Go to PubMed...
    29. Seidlerová J, Koza J, Bernat I et al. Renální denervace pro léčbu arteriální hypertenze - nezodpovězené otázky. Vnitř Lék 2014; 60(2): 134-138. Go to PubMed...
    30. Souček M. Adherence a perzistence se zaměřením na léčbu hypertenzních pacientů. Vnitř Lék 2013; 59(6): 482-485. Go to PubMed...
    31. Gavorník P, Galbavý Š. Clinical picture of arteriolosclerosis. Bratislavské Lek Listy 2001; 102(7): 326-331.
    32. Gavorník P. Rehabilitácia a interná medicína. Interná med 2013; 13(11): 498-501.
    33. Štulc T, Šnejdrlová M, Češka R. Prevence kardiovaskulárních onemocnění v běžné klinické praxi: lze dosáhnout zlepšení? Vnitř Lék 2014; 60(11): 931-936. Go to PubMed...
    34. Widimský J jr. První fixní trojkombinace perindopril arginin-indapamid-amlodipin: nový přístup v kombinační léčbě hypertenze. Vnitř Lék 2014; 60(9): 801-807. Go to PubMed...
    35. Filipovský J, Monhart V, Widimský J jr. Aktualizované stanovisko České společnosti pro hypertenzi k provádění renálních denervací u rezistentní hypertenze. Vnitř Lék 2014; 60(10): 908-910. Go to PubMed...
    36. Bulas J, Potočárová M, Filková M et al. Vplyv tuhosti aorty na centrálnu hemodynamiku a na kardiovaskulárny systém. Vnitř Lék 2013; 59(6): 444-449. Go to PubMed...
    37. Yusuf S, Rangarajan S, Teo K et al. (for the PURE Investigators). Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries. N Engl J Med 2014; 371(9): 818-827. Go to original source... Go to PubMed...
    38. Moran AE, Odden MC, Thanataveerat A et al. Cost-Effectiveness of Hypertension Therapy According to 2014 Guidelines. N Engl J Med 2015; 372(5): 447-455. Erratum: N Engl J Med 2015; 372(17): 1677. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.